Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04033497 |
|
Recruitment Status :
Recruiting
First Posted : July 26, 2019
Last Update Posted : September 25, 2023
|
Sponsor:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Ayal Aizer, MD, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 1, 2024 |
| Estimated Study Completion Date : | July 1, 2025 |